SCHEDULE: Reviva Pharmaceuticals Stake Held by CVI Investments

CVI Investments and Heights Capital Management report a combined 4.9% stake in Reviva Pharmaceuticals Holdings, Inc., primarily through warrants.

Summary

• CVI Investments, Inc. and Heights Capital Management, Inc. have jointly filed a Schedule 13G, reporting beneficial ownership of 672,811 shares of Reviva Pharmaceuticals Holdings, Inc. common stock.
• This holding represents 4.9% of the outstanding shares as of March 27, 2026.
• The reported shares are issuable upon the exercise of warrants, with a 4.99% beneficial ownership limitation on exercise.
• Heights Capital Management, Inc. acts as the investment manager for CVI Investments, Inc., and may exercise voting and dispositive power over these shares.
• The filing is an amendment (Amendment No. 1) to a previous filing, with the event date requiring this statement being March 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral; it reports an existing investment structure and ownership level without new strategic initiatives or significant changes in holdings.

Positives

• The reporting persons hold a significant stake, indicating confidence or strategic interest in Reviva Pharmaceuticals.
• The 4.9% ownership is below the 4.99% threshold that would trigger more stringent reporting requirements, suggesting a controlled and deliberate investment strategy.

Negatives

• The beneficial ownership is primarily derived from warrants, which are contingent on exercise and subject to limitations, rather than direct share ownership.
• The filing does not provide details on the cost basis or specific terms of the warrants.

Risks

• The exercise of warrants is subject to a 4.99% beneficial ownership limitation, which could restrict the ability to fully convert warrants into shares if ownership levels increase.
• The investment is concentrated in a single issuer, Reviva Pharmaceuticals Holdings, Inc., exposing the reporting persons to the specific risks of that company.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from the reporting persons regarding their future intentions with Reviva Pharmaceuticals Holdings, Inc. beyond the current ownership structure and warrant exercise limitations.

Management Comments

• Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.
• Each of the Reporting Persons hereby disclaims any beneficial ownership of any such Shares, except for their pecuniary interest therein.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing indicates a significant institutional investor, CVI Investments, managed by Heights Capital Management, has taken a notable position in Reviva Pharmaceuticals. Such filings are common for investors crossing certain ownership thresholds and provide transparency into significant shareholdings, which can influence market perception and competitor analysis.

Stakeholder Impact

• Shareholders of Reviva Pharmaceuticals Holdings, Inc.: The filing provides transparency regarding a significant institutional investor's stake, which can influence market perception and potentially impact share price dynamics.
• CVI Investments, Inc. and Heights Capital Management, Inc.: The filing confirms their investment strategy and beneficial ownership structure in Reviva Pharmaceuticals Holdings, Inc.

Next Steps

• The reporting persons will continue to monitor their beneficial ownership levels, particularly concerning the 4.99% warrant exercise limitation.
• Further filings may be required if ownership levels change significantly or if the reporting persons' intentions shift towards influencing control of Reviva Pharmaceuticals Holdings, Inc.

Key Dates

Keywords

Reviva Pharmaceuticals Holdings, Schedule 13G, CVI Investments, Heights Capital Management, beneficial ownership, warrants, SEC filing, common stock, investment management